Uresta launches in the US with $3m raise

Uresta, non-invasive solution for bladder leaks, is to launch in the United States.

Uresta, a female-owned and led health startup, aims to help women to regain confidence and control over stress urinary incontinence (SUI) without surgery or absorbent products.

To support its expansion, Uresta recently secured $3 million in funding, including $1.5 million from BDC Capital.

This investment will accelerate the company’s U.S. launch and increase awareness of its approach to bladder leakage.

Caroline Packard, PT, DPT, said: “Many women assume bladder leaks are just a normal part of ageing or childbirth, but that’s simply not true.

“Uresta is a game-changer, providing an easy-to-use, clinically proven option that allows women to get back to the activities they love without fear of leaks.”

Stress urinary incontinence, also known as light bladder leakage, which affects one in three women, can be described as bladder leakage triggered by physical activity, sneezing, laughing and coughing.

Despite the prevalence of the condition, many women either suffer in silence or resort to ineffective and costly absorbent products.

Uresta offers a reusable, hygienic alternative designed to support the bladder to prevent leaks in the first place.

Clinical studies have shown that 97 per cent of women saw a reduction of leaks when using Uresta, 90 per cent of women continue to use Uresta after 12 months, and 94 per cent would recommend Uresta to a friend.

Lauren Barker, CEO and Co-founder of Uresta, said: “Bringing Uresta to the U.S. is about more than just launching a product – it’s about offering women a real solution for bladder leaks.

“For too long, bladder leaks have controlled the lives of women. Women have been told to tolerate it with absorbent products.

“Uresta is a simple, non-invasive solution that stops leaks and puts women back in control.”